-
公开(公告)号:AU2003212246A1
公开(公告)日:2003-09-04
申请号:AU2003212246
申请日:2003-02-17
Applicant: SORG CLEMENS , ROTH JOHANNES
Inventor: SORG CLEMENS , ROTH JOHANNES
IPC: G01N33/68
-
公开(公告)号:CA2474890A1
公开(公告)日:2003-08-21
申请号:CA2474890
申请日:2003-02-17
Applicant: SORG CLEMENS , ROTH JOHANNES
Inventor: SORG CLEMENS , ROTH JOHANNES
IPC: G01N33/53 , C12N15/09 , C12Q1/68 , G01N33/564 , G01N33/577 , G01N33/68
Abstract: The present invention is directed to a method for diagnosing inflammatory diseases based on the marker CALGRANULIN C, particularly for diagnosing specific stages of inflammatory diseases and/or for determining the risk of relapse and/or for discriminating between diseases with similar symptoms, sa id method comprising the steps of (a) obtaining a biological sample of mammalia n body fluid or tissue to be diagnosed; (b) determining the amount and/or con~centration of CALGRANULIN C polypeptide and/or nucleic acids encoding th e polypeptide present in said biological sample; and (c) comparing the amount and/or concentration of CALGRANULIN C polypeptide determine in said biologic al sample with the amount and/or concentration of CALGRANULIN C polypeptide as determined in a control sample and/or comparing the amount and/or concentration of nucleic acids encoding CALGRANULIN C polypeptide determined in said biological sample with the amount and/or concentration of nucleic acids encoding CALGRANULIN C polypeptides measured in a control sample, wherein the difference in the amount of CALGRANULIN C polypeptide and/or nucleic acids encoding the polypeptide is indicative for the stages of the disease to be diagnosed.
-
公开(公告)号:AU2003212245A8
公开(公告)日:2003-09-04
申请号:AU2003212245
申请日:2003-02-17
Applicant: ROTH JOHANNES , SWITCH BIOTECH AG , SORG CLEMENS
Inventor: SORG CLEMENS , ROTH JOHANNES
IPC: G01N33/53 , C12N15/09 , C12Q1/68 , G01N33/564 , G01N33/577 , G01N33/68
Abstract: The present invention is directed to a method for diagnosing inflammatory diseases based on the marker CALGRANULIN C, particularly for diagnosing specific stages of inflammatory diseases and/or for determining the risk of relapse and/or for discriminating between diseases with similar symptoms, said method comprising the steps of (a) obtaining a biological sample of mammalian body fluid or tissue to be diagnosed; (b) determining the amount and/or concentration of CALGRANULIN C polypeptide and/or nucleic acids encoding the polypeptide present in said biological sample; and (c) comparing the amount and/or concentration of CALGRANULIN C polypeptide determine in said biological sample with the amount and/or concentration of CALGRANULIN C polypeptide as determined in a control sample and/or comparing the amount and/or concentration of nucleic acids encoding CALGRANULIN C polypeptide determined in said biological sample with the amount and/or concentration of nucleic acids encoding CALGRANULIN C polypeptides measured in a control sample, wherein the difference in the amount of CALGRANULIN C polypeptide and/or nucleic acids encoding the polypeptide is indicative for the stages of the disease to be diagnosed.
-
公开(公告)号:AU2003212246A8
公开(公告)日:2003-09-04
申请号:AU2003212246
申请日:2003-02-17
Applicant: ROTH JOHANNES , SORG CLEMENS
Inventor: SORG CLEMENS , ROTH JOHANNES
-
公开(公告)号:AU2003212245A1
公开(公告)日:2003-09-04
申请号:AU2003212245
申请日:2003-02-17
Applicant: ROTH JOHANNES , SWITCH BIOTECH AG , SORG CLEMENS
Inventor: ROTH JOHANNES , SORG CLEMENS
IPC: G01N33/53 , C12N15/09 , C12Q1/68 , G01N33/564 , G01N33/577 , G01N33/68
Abstract: The present invention is directed to a method for diagnosing inflammatory diseases based on the marker CALGRANULIN C, particularly for diagnosing specific stages of inflammatory diseases and/or for determining the risk of relapse and/or for discriminating between diseases with similar symptoms, said method comprising the steps of (a) obtaining a biological sample of mammalian body fluid or tissue to be diagnosed; (b) determining the amount and/or concentration of CALGRANULIN C polypeptide and/or nucleic acids encoding the polypeptide present in said biological sample; and (c) comparing the amount and/or concentration of CALGRANULIN C polypeptide determine in said biological sample with the amount and/or concentration of CALGRANULIN C polypeptide as determined in a control sample and/or comparing the amount and/or concentration of nucleic acids encoding CALGRANULIN C polypeptide determined in said biological sample with the amount and/or concentration of nucleic acids encoding CALGRANULIN C polypeptides measured in a control sample, wherein the difference in the amount of CALGRANULIN C polypeptide and/or nucleic acids encoding the polypeptide is indicative for the stages of the disease to be diagnosed.
-
公开(公告)号:ES2394962T3
公开(公告)日:2013-02-07
申请号:ES03708103
申请日:2003-02-17
Applicant: SORG CLEMENS , ROTH JOHANNES , UNIV MUENSTER WILHELMS
Inventor: SORG CLEMENS , ROTH JOHANNES
IPC: G01N33/53 , G01N33/564 , C12N15/09 , C12Q1/68 , G01N33/577 , G01N33/68
Abstract: Método para el diagnóstico de enfermedades inflamatorias seleccionadas de artritis reumatoide, artritisseronegativa, artritis juvenil y artritis reumatoide juvenil de comienzo sistémico (ARJS), que comprende lasetapas dea) determinar la cantidad y/o concentración de polipéptido de calgranulina C en una muestra de suero de unpaciente; yb) comparar la cantidad y/o concentración de polipéptido de calgranulina C determinada en dicha muestrade suero con la cantidad y/o concentración de polipéptido de calgranulina C determinada en una muestracontrol de suero,en el que un aumento en la cantidad de polipéptido de calgranulina C en la muestra de suero encomparación con la muestra control es indicativo de dicha enfermedad
-
公开(公告)号:US1015588A
公开(公告)日:1912-01-23
申请号:US1910591002
申请日:1910-11-07
Applicant: ROTH JOHANNES
Inventor: ROTH JOHANNES
CPC classification number: B28B11/12
-
公开(公告)号:DE102021000985A1
公开(公告)日:2022-08-25
申请号:DE102021000985
申请日:2021-02-24
Applicant: ROTH JOHANNES
Inventor: ROTH JOHANNES
Abstract: Die vorliegende Erfindung betrifft einen Beißring zur Durchführung aller Arten endoskopischer Untersuchungen des oberen Gastrointestinaltraktes mit einem für ein endoskopisches Instrument eine Durchgangsöffnung bietenden Mundstück und den dazugehörigen Haltebögen, dadurch gekennzeichnet, dass die vertikalen Seiten (b) des Mundstückes (a) bei vertikalem Druck komprimierbar sind. Dabei bestehen die Seitenteile (b) aus einer glatten Oberfläche aus thermoplastischem elastomeren Material, so dass keine Reibungsdefekte am Endoskop entstehen. Sind die Seitenteile (b) ziehharmonikaähnlich angeordnet wird medial dieser Seitenteile (b) eine Membran (d), ebenfalls aus einem thermoplastischen elastomeren Material eingefügt, die das Endoskop vor möglichen Reibungsdefekten schützt.
-
公开(公告)号:DE102016012235B8
公开(公告)日:2018-04-19
申请号:DE102016012235
申请日:2016-10-10
Applicant: ROTH JOHANNES
Inventor: ROTH JOHANNES
-
公开(公告)号:CH33311A
公开(公告)日:1905-12-15
申请号:CH33311D
申请日:1905-05-20
Applicant: ROTH JOHANNES
Inventor: ROTH JOHANNES
-
-
-
-
-
-
-
-
-